Literature DB >> 8836866

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

J E Hokanson1, M A Austin.   

Abstract

OBJECTIVES: Despite nearly 40 years of research, the role of plasma triglyceride as a risk factor for cardiovascular disease remains elusive. The objectives of the present study were to quantify the magnitude of the association between triglyceride and cardiovascular disease in the general population, and to determine whether this relationship is independent of high-density lipoprotein (HDL) cholesterol, using the semi-quantitative techniques of metaanalysis. METHODS AND
DESIGN: Seventeen studies were selected for the analysis based on published reports of population-based, prospective studies, including 46413 men and 10864 women. To insure comparability, only studies reporting the association between fasting triglyceride levels and incident cardiovascular endpoints were included. Using standard meta-analysis calculations, relative risks (RR) and 95% confidence intervals (CI) were calculated and standardized with respect to a 1 mmol/l increase in triglyceride. Multivariable-adjusted RRs were determined for the six studies in men and two studies in women that reported adjustments for HDL cholesterol.
RESULTS: For men and women, the univariate RRs for triglyceride were 1.32 (95% Cl 1.26-1.39) and 1.76 (95% Cl 1.50-2.07), respectively, indicating an approximately 30% increased risk in men and a 75% increase in women. Adjustment of HDL cholesterol and other risk factors attenuated these RRs to 1.14 (95% Cl 1.05-1.28) and 1.37 (95% Cl 1.13-1.66), respectively, which were still statistically significant values.
CONCLUSION: Based on combined data from prospective studies, triglyceride is a risk factor for cardiovascular disease for both men and women in the general population, independent of HDL cholesterol. These finding demonstrate the necessity for clinical trials to evaluate whether lowering plasma triglyceride decreases the risk of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836866

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  442 in total

1.  Abdominal obesity and the "hypertriglyceridaemic waist" phenotype.

Authors:  P Little; C D Byrne
Journal:  BMJ       Date:  2001-03-24

2.  Triglyceride as a risk factor, epidemiology.

Authors:  M Miller
Journal:  Lipids       Date:  1999       Impact factor: 1.880

Review 3.  The effect of n-3 fatty acids on low density lipoprotein subfractions.

Authors:  B A Griffin
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 4.  Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease.

Authors:  H N Ginsberg
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 2.931

5.  Light-to-moderate alcohol intake reduces lipid accumulation product and attenuates its relation to hypertension.

Authors:  I Wakabayashi
Journal:  J Hum Hypertens       Date:  2014-11-13       Impact factor: 3.012

6.  Role of LXRs in control of lipogenesis.

Authors:  J R Schultz; H Tu; A Luk; J J Repa; J C Medina; L Li; S Schwendner; S Wang; M Thoolen; D J Mangelsdorf; K D Lustig; B Shan
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

7.  A genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia.

Authors:  Mario Falchi; Paola Forabosco; Evelina Mocci; Cesare Cappio Borlino; Andrea Picciau; Emanuela Virdis; Ivana Persico; Debora Parracciani; Andrea Angius; Mario Pirastu
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

8.  Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.

Authors:  Jeremy D Furtado; Hannia Campos; Anne E Sumner; Lawrence J Appel; Vincent J Carey; Frank M Sacks
Journal:  Am J Clin Nutr       Date:  2010-09-08       Impact factor: 7.045

9.  Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.

Authors:  Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Konstantinos Tziomalos; Athanasios Skaperdas; Efstathios Pagourelias; Athina Pirpasopoulou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

Review 10.  Aggressive diets and lipid responses.

Authors:  Claudia Panzer; Caroline M Apovian
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.